1. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Issue 9 (September 2021) Authors: Vesikari, Timo; Langley, Joanne M; Segall, Nathan; Ward, Brian J; Cooper, Curtis; Poliquin, Guillaume; Smith, Bruce; Gantt, Soren; McElhaney, Janet E; Dionne, Marc; van Damme, Pierre; Leroux-Roels, Isabel; Leroux-Roels, Geert; Machluf, Nathalie; Spaans, Johanna N; Yassin-Rajkumar, Bebi; Anderson,... Journal: Lancet infectious diseases Issue: Volume 21:Issue 9(2021) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗